U.S. markets open in 3 hours 31 minutes

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
91.93-0.22 (-0.24%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
1,045,400
1,045,900
788,087
451,240
161,626
Cost of Revenue
10,900
10,100
7,428
4,889
1,254
Gross Profit
1,034,500
1,035,800
780,659
446,351
160,372
Operating Expense
734,400
708,300
554,104
409,456
291,733
Operating Income
300,100
327,500
226,555
36,895
-131,361
Net Non Operating Interest Income Expense
-31,000
-32,800
-31,963
-30,530
-19,523
Other Income Expense
-174,100
-188,000
-148,050
15,476
8,342
Pretax Income
95,000
106,700
46,542
21,841
-142,542
Tax Provision
-307,000
-300,600
9,530
730
-
Net Income Common Stockholders
402,000
407,300
37,012
21,111
-142,542
Diluted NI Available to Com Stockholders
402,000
407,300
37,012
21,111
-142,542
Basic EPS
-
-
0.40
0.23
-1.62
Diluted EPS
-
-
0.39
0.22
-1.62
Basic Average Shares
-
-
91,600
90,235
88,089
Diluted Average Shares
-
-
95,700
95,386
88,089
Total Operating Income as Reported
135,600
163,000
72,283
36,895
-131,361
Total Expenses
745,300
718,400
561,532
414,345
292,987
Net Income from Continuing & Discontinued Operation
402,000
407,300
37,012
21,111
-142,542
Normalized Income
506,460
544,540
154,747
6,152
-150,904
Interest Expense
31,000
32,800
31,963
30,530
19,523
Net Interest Income
-31,000
-32,800
-31,963
-30,530
-19,523
EBIT
126,000
139,500
78,505
52,371
-123,019
EBITDA
135,000
-
-
-
-
Reconciled Cost of Revenue
10,900
10,100
7,428
4,889
1,254
Reconciled Depreciation
9,000
8,600
7,452
4,024
2,400
Net Income from Continuing Operation Net Minority Interest
402,000
407,300
37,012
21,111
-142,542
Total Unusual Items Excluding Goodwill
-174,100
-188,000
-148,050
15,476
8,362
Total Unusual Items
-174,100
-188,000
-148,050
15,476
8,362
Normalized EBITDA
309,100
336,100
234,007
40,919
-128,981
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-69,640
-50,760
-30,315
517.2602
0